Sihuan Pharma to commence type II diabetes drug trial
Pinoxacin Hydrochloride, a category 1.1 drug, is a DPP-4 inhibitor class of oral hypoglycemic agents used to enhance the function of endogenous insulin for improving glycemic control and
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.
As part of the deal, both the firms will evaluate anti-cancer drug conjugate by using Spirogen’s proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies generated
Healthagen, which tackles the fundamental needs of greater value, coordination and transparency in health care, uses Aetna’s population health management solutions and health information technologies from businesses, which
Under the new collaboration, Bosch will use its evidence-based telehealth solutions with GreatCall’s expertise to develop wireless health and safety solutions for older consumers and their families. Bosch